Rapid Progressing Allele HLA-B35 Px Restricted Anti-HIV-1 CD8+ T Cells Recognize Vestigial CTL Epitopes

PLoS ONE

Volumn 5, Issue 4, 2010, Pages

  Willberg, Christian B ^a   Garrison, Keith E ^a   Jones, R Brad ^b   Meiklejohn, Duncan J ^a   Spotts, Gerald ^a   Liegler, Teri J ^a   Ostrowski, Mario A ^b   Karlsson, Annika C ^c,d   Hecht, Frederick M ^a   Nixon, Douglas F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

^c KAROLINSKA INSTITUTE   (Sweden)

^d The Swedish Institute for Infectious Disease Control   (Swaziland)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; HLA B35 ANTIGEN; EPITOPE; T LYMPHOCYTE RECEPTOR;

ANTIGEN EXPRESSION; ARTICLE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; HLA MATCHING; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; NONHUMAN; VIRUS LOAD; VIRUS MUTANT; ALLELE; BLOOD; CD4 LYMPHOCYTE COUNT; DISEASE COURSE; GENETIC VARIABILITY; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; LONGITUDINAL STUDY;

HUMAN IMMUNODEFICIENCY VIRUS 1;

ALLELES; CD4 LYMPHOCYTE COUNT; CD8-POSITIVE T-LYMPHOCYTES; DISEASE PROGRESSION; EPITOPES, T-LYMPHOCYTE; GENETIC VARIATION; HIV INFECTIONS; HIV-1; HLA-B35 ANTIGEN; HUMANS; LONGITUDINAL STUDIES; T-CELL ANTIGEN RECEPTOR SPECIFICITY; T-LYMPHOCYTES, CYTOTOXIC; VIRAL LOAD;

EID: 77956329866     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0010249     Document Type: Article

References (23)

1. Kiepiela P, Leslie AJ, Honeyborne I, Ramduth D, Thobakgale C, et al. (2004) Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA. Nature 432: 769-775.
2. Fellay J, Shianna KV, Ge D, Colombo S, Ledergerber B, et al. (2007) A wholegenome association study of major determinants for host control of HIV-1. Science 317: 944-947.
3. Dean M, Carrington M, Winkler C, Huttley GA, Smith MW, et al. (1996) Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study. Science 273: 1856-1862.
4. Carrington M, Bontrop RE (2002) Effects of MHC class I on HIV/SIV disease in primates. AIDS 16: S105-114.
5. Ahuja SK, Kulkarni H, Catano G, Agan BK, Camargo JF, et al. (2008) CCL3L1-CCR5 genotype influences durability of immune recovery during antiretroviral therapy of HIV-1-infected individuals. Nat Med 14: 413-420.
6. Carrington M, O'Brien SJ (2003) The influence of HLA genotype on AIDS. Annu Rev Med 54: 535-551.
7. Scherer A, Frater J, Oxenius A, Agudelo J, Price DA, et al. (2004) Quantifiable cytotoxic T lymphocyte responses and HLA-related risk of progression to AIDS. Proc Natl Acad Sci USA 101: 12266-12270.
8. Gao X, Nelson GW, Karacki P, Martin MP, Phair J, et al. (2001) Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS. N Engl J Med 344: 1668-1675.
9. Barber LD, Gillece-Castro B, Percival L, Li X, Clayberger C, et al. (1995) Overlap in the repertoires of peptides bound in vivo by a group of related class I HLA-B allotypes. Curr Biol 5: 179-190.
10. Jin X, Gao X, Ramanathan M, Deschenes GR, Nelson GW, et al. (2002) Human immunodeficiency virus type 1 (HIV-1)-specific CD8+-T-cell responses for groups of HIV-1-infected individuals with different HLA-B*35 genotypes. J Virol 76: 12603-12610.
11. Hecht FM, Busch MP, Rawal B, Webb M, Rosenberg E, et al. (2002) Use of laboratory tests and clinical symptoms for identification of primary HIV infection. AIDS 16: 1119.
12. Sandberg JK, Fast NM, Jordan KA, Furlan SN, Barbour JD, et al. (2003) HIVspecific CD8+ T cell function in children with vertically acquired HIV-1 infection is critically influenced by age and the state of the CD4+ T cell compartment. J Immunol 170: 4403-4410.
13. Larsson M, Jin X, Ramratnam B, Ogg GS, Engelmayer J, et al. (1999) A recombinant vaccinia virus based ELISPOT assay detects high frequencies of Pol-specific CD8 T cells in HIV-1-positive individuals. AIDS 13: 767-777.
14. Karlsson AC, Martin JN, Younger SR, Bredt BM, Epling L, et al. (2003) Comparison of the ELISPOT and cytokine flow cytometry assays for the enumeration of antigen-specific T cells. Journal of Immunological Methods 283: 141-153.
15. Menéndez-Arias L, Mas A, Domingo E (1998) Cytotoxic T-lymphocyte responses to HIV-1 reverse transcriptase (review). Viral Immunol 11: 167-181.
16. Sipsas NV, Kalams SA, Trocha A, He S, Blattner WA, et al. (1997) Identification of type-specific cytotoxic T lymphocyte responses to homologous viral proteins in laboratory workers accidentally infected with HIV-1. J Clin Invest 99: 752-762.
17. Grant RM, Kuritzkes DR, Johnson VA, Mellors JW, Sullivan JL, et al. (2003) Accuracy of the TRUGENE HIV-1 genotyping kit. J Clin Microbiol 41: 1586-1593.
18. Kuritzkes DR, Grant RM, Feorino P, Griswold M, Hoover M, et al. (2003) Performance characteristics of the TRUGENE HIV-1 Genotyping Kit and the Opengene DNA Sequencing System. J Clin Microbiol 41: 1594-1599.
19. Turnbull EL, Lopes AR, Jones NA, Cornforth D, Newton P, et al. (2006) HIV-1 epitope-specific CD8+ T cell responses strongly associated with delayed disease progression cross-recognize epitope variants efficiently. J Immunol 176: 6130-6146.
20. Nicholson LB, Anderson AC, Kuchroo VK (2000) Tuning T cell activation threshold and effector function with cross-reactive peptide ligands. International Immunology 12: 205-213.
21. Gold JS, Ferrone CR, Guevara-Patiño JA, Hawkins WG, Dyall R, et al. (2003) A single heteroclitic epitope determines cancer immunity after xenogeneic DNA immunization against a tumor differentiation antigen. J Immunol 170: 5188-5194.
22. Dyall R, Bowne WB, Weber LW, LeMaoult J, Szabo P, et al. (1998) Heteroclitic immunization induces tumor immunity. The Journal of Experimental Medicine 188: 1553-1561.
23. Brown ME, Miao H, McKee MD (2007) Recognition of carcinoembryonic antigen peptide and heteroclitic peptide by peripheral blood T lymphocytes. J Immunother 30: 350-358.